Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1976 Jul;25(1):1–5.

Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.

M Jondal
PMCID: PMC1541383  PMID: 186222

Abstract

The capacity of antibodies, directed against EBV-determined membrane antigens (MA), to induce antibody-dependent cellular cytotoxicity (ADCC) against EBV superinfected lymphoid cell lines was investigated. Such reactive antibodies were found, at high dilutions, in sera from normal EBV-positive persons but not in sera from EBV-negative persons. Sera from patients with acute infectious mononucleosis (IM), which develop EBV-specific killer T cells, did not induce ADCC. The difference in specificity between ADCC and EBV-specific killer T cells is briefly discussed.

Full text

PDF
2

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams A. Concentration of Epstein-Barr virus from cell culture fluids with polyethylene glycol. J Gen Virol. 1973 Sep;20(3):391–394. doi: 10.1099/0022-1317-20-3-391. [DOI] [PubMed] [Google Scholar]
  2. Carter R. L. Infectious mononucleosis: model for self-limiting lymphoproliferation. Lancet. 1975 Apr 12;1(7911):846–849. doi: 10.1016/s0140-6736(75)93014-7. [DOI] [PubMed] [Google Scholar]
  3. Gunvén P., Klein G. Blocking of direct membrane immunofluorescence in titration of membrane-reactive antibodies associated with Epstein-Barr virus. J Natl Cancer Inst. 1971 Sep;47(3):539–548. [PubMed] [Google Scholar]
  4. Härfast B., Andersson T., Perlmann P. Human lymphocyte cytotoxicity against mumps virus-infected target cells. Requirement for non-T cells. J Immunol. 1975 Jun;114(6):1820–1823. [PubMed] [Google Scholar]
  5. Jondal M. Surface markers on human B and T lymphocytes. IV. Distribution of surface markers on resting and blast-transformed lymphocytes. Scand J Immunol. 1974;3(6):739–747. doi: 10.1111/j.1365-3083.1974.tb01309.x. [DOI] [PubMed] [Google Scholar]
  6. Klein G., Pearson G., Henle G., Henle W., Diehl V., Niederman J. C. Relation between Epstein-- Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. II. Comparison of cells and sera from patients with Burkitt's lymphoma and infectious mononucleosis. J Exp Med. 1968 Nov 1;128(5):1021–1030. doi: 10.1084/jem.128.5.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kreth W. H., Käckell M. Y., ter Meulen V. Demonstration of in vitro lymphocyte-mediated cytotoxicity against measles virus in SSPE. J Immunol. 1975 Mar;114(3):1042–1046. [PubMed] [Google Scholar]
  8. Labowskie R., Edelman R., Rustigian R., Bellanti J. A. Studies of cell-mediated immunity to measles virus by in vitro lymphocyte-mediated cytotoxicity. J Infect Dis. 1974 Mar;129(3):233–239. doi: 10.1093/infdis/129.3.233. [DOI] [PubMed] [Google Scholar]
  9. Miller G. The oncogenicity of Epstein-Barr virus. J Infect Dis. 1974 Aug;130(2):187–205. doi: 10.1093/infdis/130.2.187. [DOI] [PubMed] [Google Scholar]
  10. Papamichail M., Sheldon P. J., Holborow E. J. T- and B-cell subpopulations in infectious mononucleosis. Clin Exp Immunol. 1974 Sep;18(1):1–11. [PMC free article] [PubMed] [Google Scholar]
  11. Prevost J., Orr T. W., Pearson G. R. Augmentation of lymphocyte cytotoxicity by antibody to herpesvirus saimiri associated antigens. Proc Natl Acad Sci U S A. 1975 May;72(5):1671–1675. doi: 10.1073/pnas.72.5.1671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sheldon P. J., Hemsted E. H., Papamichail M., Holborow E. J. Thymic origin of atypical lymphoid cells in infectious mononucleosis. Lancet. 1973 May 26;1(7813):1153–1155. doi: 10.1016/s0140-6736(73)91148-3. [DOI] [PubMed] [Google Scholar]
  13. Svedmyr E., Jondal M. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1622–1626. doi: 10.1073/pnas.72.4.1622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Valdimarsson H., Agnarsdottir G., Lachmann P. J. Cellular immunity in subacute sclerosing panencephalitis. Proc R Soc Med. 1974 Nov;67(11):1125–1129. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES